Author:
Seabra Joana,Ferreira Alexandra,Rocha Artur,André Ana,Trindade Carlos,Cortez Luís
Publisher
Fundacion de la Sociedad Espanola de Cirugia de la Obesidad (FUNSECO)
Reference12 articles.
1. Magge D, Holtzman MP. Gastric Adenocarcinoma in patients with Roux-en-Y Gastric bypass: A case series. Surgery for Obesity and Related Diseases. 2015 Sep;11(5):e35–8.
2. Report on cancer - Portugal [Internet]. Lyon: Global Cancer Observatory; 2021 Mar [cited 2022 Nov 19] p. 1–2. Available from: https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf
3. Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, et al. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol. 2017 Dec 11;17:157.
4. Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019 Apr;51(4):365–88.
5. Inoue H, Rubino F, Shimada Y, Lindner V, Inoue M, Riegel P, et al. Risk of gastric cancer after Roux-en-Y gastric bypass. Arch Surg. 2007 Oct;142(10):947–53.